Acne News with Dr. Adam Friedman
Straight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris …
Straight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris … 
What organism caused this disease?
A. Kytococcus sedentarius
B. Candida albicans
C. Staphylococcus aureus
D. Corynebacterium tenuis
E. Corynebacterium diphtheriae
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
I believe one of the most valuable aspects of attending conferences such as ODAC is to “fill in the gaps” in important topics that are often missing in our regular dermatology training. While US dermatology residency programs provide the foundation for providing the highest level of dermatologic care to our patients, they are often lacking in teaching the business side of medicine and practica … 
What complication can occur if this disease is left untreated?
A. Development of a squamous cell carcinoma
B. Testicular torsion
C. Erectile dysfunction
D. Impotence
E. Pseudo-ainhum
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Atopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …